| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO and COO | Chief Financial Officer | Chief Executive Officer
2 companies
Plavan Matthew T serves as a CFO and COO at ORGN and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 6 buys and 6 sells. Those positions are worth an estimated $306K at current prices.
Historically, Plavan Matthew T's trades have earned a strong insider score of 77/100 across 6 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +74.2%.
The biggest single holding is ORGN (~$261K) as CFO and COO. The recent filings there lean toward selling, a net 356,225 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2019 | RKDA Arcadia Biosciences, Inc. | Chief Executive Officer | Buy | 2,000 | $6.51 | $13,013.50 | +25.0% |